Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 40, 2010 - Issue 10
196
Views
0
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism

Metabolism and excretion of [14C]taranabant, a cannabinoid-1 inverse agonist, in humans

, , , , , , , , , , , , , , , & show all
Pages 691-700 | Received 18 Jun 2010, Accepted 17 Jul 2010, Published online: 19 Aug 2010
 

Abstract

  1. Taranabant (N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide or MK-0364) is an orally active inverse agonist of the cannabinoid 1 (CB-1) receptor that was under development for the management of obesity. The metabolism and excretion of taranabant were investigated following a single oral dose of 5 mg/201 μCi [14C]taranabant to six healthy male subjects. The overall excretion recovery of the administered radioactivity was nearly quantitative (∼ 92%), with the majority of the dose (∼ 87%) excreted into faeces and a much smaller fraction (∼ 5%) into urine.

  2. Taranabant was absorbed rapidly, with Cmax of radioactivity attained at 1–2-h postdose. The parent compound and its monohydroxylated metabolite, M1, were the major radioactive components circulating in plasma and comprised ∼ 12–24% and 33–42%, respectively, of the plasma radioactivity for up to 48 h. A second monohydroxylated metabolite, designated as M1a, represented ∼ 10–12% of the radioactivity in the 2- and 8-h postdose plasma profiles.

  3. Metabolite profiles of the faeces samples consisted mainly of the (unabsorbed) parent compound and multiple diastereomeric carboxylic acid derivatives derived from oxidation of the geminal methyl group of the parent compound and of the hydroxylated metabolite/s. These data suggest that, similar to rats and monkeys, taranabant is primarily eliminated in humans via oxidative metabolism and excretion of metabolites via the biliary/faecal route.

Acknowledgements

The authors would like to acknowledge Drs. Tom Baillie and Stella Vincent for helpful discussions.

Declaration of interest

All studies reported here were supported by Merck and Co and conducted by employees of Merck and Co. The authors report no conflicts of interest.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 897.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.